SOFIE Biosciences, Inc., a radiopharmaceutical supplier and contract manufacturing organization, and Jubilant Radiopharma, a division of Jubilant Pharma Ltd., have entered into a strategic partnership under which Jubilant Pharma will be a strategic partner to SOFIE, enabling SOFIE to expand production capacity, advance its theranostic pipeline, and support novel PET diagnostic manufacturing and distribution within the U.S. As part of the agreement, Jubilant Radiopharma will invest $25 millio...